Search Within

Brian Kushner

Formats
  1. Journal Article (182)
  2. Meeting Abstract (113)
  3. Conference Paper (9)
  4. Book Section (4)
  5. Editorial (2)
  6. Guidelines (1)
  7. Review (1)
Groups
  1. Neuroblastoma Service (312)
  2. Pediatrics, Department of (312)
  3. GSK Faculty (233)
  4. Tow Center for Developmental Oncology (TCDO) (233)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (230)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (227)

More Groups

People
  1. Nai-Kong Cheung (227)
  2. Shakeel Modak (155)
  3. Kim Kramer (133)
  4. Michael La Quaglia (80)
  5. Ellen Basu (69)
  6. Stephen Roberts (63)

More People

Years
  1. 2025 (3)
  2. 2024 (9)
  3. 2023 (18)
  4. 2022 (9)
  5. 2021 (13)
  6. 2020 (14)

More Years

Publications
  1. Pediatric Blood and Cancer (66)
  2. Journal of Clinical Oncology (60)
  3. International Journal of Radiation Oncology, Biology, Physics (26)
  4. Cancer (19)
  5. Medical and Pediatric Oncology (10)
  6. Neuro-Oncology (9)

More Publications

Publishers
  1. Wiley Periodicals, Inc (66)
  2. American Society of Clinical Oncology (61)
  3. Elsevier Inc. (33)
  4. Wiley Blackwell (19)
  5. American Association for Cancer Research (14)
  6. Oxford University Press (14)

More Publishers

Results (312)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of the combination of bevacizumab plus irinotecan and temozolomide for relapsed or refractory neuroblastoma: Preliminary results
    Meeting Abstract

    Modak, S.; Kushner, B. H.; Kramer, K.; Basu, E.; Roberts, S. S.; Cheung, N. K. V.
    Pediatric Blood and Cancer (2012)

    Fulltext@MSK | Save
  • Haploidentical natural killer cells plus monoclonal antibody 3F8 for resistant high-risk neuroblastoma: Preliminary results of an ongoing phase I study
    Meeting Abstract

    Modak, S.; Cheung, N. K. V.; Kushner, B. H.; Kramer, K.; Basu, E.; Roberts, S. S.; Gallagher, M.; Hsu, K.
    Pediatric Blood and Cancer (2012)

    Fulltext@MSK | Save
  • Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte- macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission
    Journal Article

    Cheung, N. K. V.; Cheung, I. Y.; Kushner, B. H.; Ostrovnaya, I.; Chamberlain, E.; Kramer, K.; Modak, S.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Plerixafor plus granulocyte-colony stimulating factor for autologous hematopoietic stem cell mobilization in patients with metastatic neuroblastoma
    Journal Article

    Modak, S.; Cheung, I. Y.; Kushner, B. H.; Kramer, K.; Reich, L.; Cheung, N. K. V.
    Pediatric Blood and Cancer (2012)

    Fulltext@MSK | Save
  • Combined anti-angiogenesis and radioimmunotherapy for neuroblastoma: Results of a phase I study
    Meeting Abstract

    Modak, S.; Kushner, B.; Kramer, K.; Cheung, N. K.
    Pediatric Blood and Cancer (2011)

    Fulltext@MSK | Save
  • Successful multifold dose escalation of anti-GD2 monoclonal antibody 3F8 in patients with neuroblastoma: A phase I study
    Journal Article

    Kushner, B. H.; Kramer, K.; Modak, S.; Cheung, N. K. V.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • High-dose cyclophosphamide-irinotecan-vincristine for primary refractory neuroblastoma
    Journal Article

    Kushner, B. H.; Kramer, K.; Modak, S.; Yataghene, K.; Cheung, N. K. V.
    European Journal of Cancer (2011)

    Fulltext@MSK | Save
  • High-dose carboplatin-irinotecan-temozolomide: Treatment option for neuroblastoma resistant to topotecan
    Journal Article

    Kushner, B. H.; Kramer, K.; Modak, S.; Cheung, N. K. V.
    Pediatric Blood and Cancer (2011)

    Fulltext@MSK | Save
  • NK cell killer Ig-like receptor (KIR) genotype as a novel biomarker for neuroblastoma patients receiving anti-GD2 monoclonal antibody 3F8
    Meeting Abstract

    Venstrom, J. M.; Zheng, J.; Kushner, B. H.; Modak, S.; Danis, K. E.; Cheung, I. Y.; Dupont, B.; Cheung, N. K.; Hsu, K. C.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Arsenic trioxide as radiosensitizer for 131i-mibg therapy: Results of a pilot phase II study
    Meeting Abstract

    Modak, S.; Pandit-Taskar, N.; Carrasquillo, J.; Kramer, K.; Kushner, B. H.; Zanzonico, P.; Smith-Jones, P.; Larson, S.; Cheung, N. K. V.
    Pediatric Blood and Cancer (2010)

    Fulltext@MSK | Save